Conference
P-252 Interim report: A phase III randomized double blindchemoprevention trial of selenium supplementation in persons with resected stage I non small cell lung cancer
Authors
Karp D; Lee S; Keller S; Johnson D; Kucuk O; Clamon G; Marks R; Johnston M; Okawara G; Ruckdeschel J
Volume
49
Publisher
Elsevier
Publication Date
July 2005
DOI
10.1016/s0169-5002(05)80746-9
Conference proceedings
Lung Cancer
ISSN
0169-5002